Highlights
NASDAQ: CKPT       Checkpoint Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
2.05   -0.17 (7.66%)  1.95 - 2.31  576,000

Overview

 
Avg Volume (4 weeks):207,942
4 Weeks Range:1.725 - 2.422
4 Weeks Price Volatility (%):
46.63%
52 Weeks Range:1.12 - 5.20
52 Weeks Price Volatility (%):
22.79%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). Checkpoint emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP).

  Be the first to like this.
 


 

4065  3960  648  241 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GRPN 1.70-1.35 
 ACHN 6.760.00 
 SPCE 37.35+7.05 
 CHK 0.479+0.042 
 NIO 4.08+0.28 
 ZOM 0.24+0.106 
 F 8.00-0.06 
 AMD 58.90+2.01 
 GE 12.61-0.14 
 PLUG 5.72+0.87 
Partners & Brokers